Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · IEX Real-Time Price · USD
3.34 -0.14 (-4.02%)
Oct 25, 2021 4:00 PM EDT - Market closed
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
| Year | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|
| Selling, General & Admin | 5.07 | 4.28 | 6.62 | 0.81 | 0.26 |
| Research & Development | 5.85 | 3.97 | 0.37 | 0.18 | 0.15 |
| Operating Expenses | 10.93 | 8.24 | 6.99 | 1 | 0.41 |
| Operating Income | -10.93 | -8.24 | -6.99 | -1 | -0.41 |
| Interest Expense / Income | 0 | 0 | 1.17 | 0.14 | 0.01 |
| Other Expense / Income | -0.03 | 0.35 | 3.48 | -0 | -0 |
| Pretax Income | -10.89 | -8.59 | -11.63 | -1.14 | -0.42 |
| Net Income | -10.89 | -8.59 | -11.63 | -1.14 | -0.42 |
| Net Income Common | -10.89 | -8.59 | -11.63 | -1.14 | -0.42 |
| Shares Outstanding (Basic) | 12 | 10 | 5 | 3 | 3 |
| Shares Outstanding (Diluted) | 12 | 10 | 5 | 3 | 3 |
| Shares Change | 26.50% | 107.01% | 45.80% | 0.20% | - |
| EPS (Basic) | -0.87 | -0.87 | -2.44 | -0.35 | -0.13 |
| EPS (Diluted) | -0.87 | -0.87 | -2.44 | -0.35 | -0.13 |
| Free Cash Flow Per Share | -0.61 | -0.64 | -0.53 | -0.15 | -0.08 |
| EBITDA | -10.89 | -8.59 | -10.46 | -0.99 | -0.41 |
| EBIT | -10.89 | -8.59 | -10.46 | -0.99 | -0.41 |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).